...
首页> 外文期刊>MBio >Binding of Host Cell Surface Protein Disulfide Isomerase by Anaplasma phagocytophilum Asp14 Enables Pathogen Infection
【24h】

Binding of Host Cell Surface Protein Disulfide Isomerase by Anaplasma phagocytophilum Asp14 Enables Pathogen Infection

机译:宿主细胞表面蛋白二硫化物异构酶的结合<命名含量含量=“属型”> Anaplasma吞噬细胞素 ASP14使病原体感染能够

获取原文

摘要

Diverse intracellular pathogens rely on eukaryotic cell surface disulfide reductases to invade host cells. Pharmacologic inhibition of these enzymes is cytotoxic, making it impractical for treatment. Identifying and mechanistically dissecting microbial proteins that co-opt surface reductases could reveal novel targets for disrupting this common infection strategy. Anaplasma phagocytophilum invades neutrophils by an incompletely defined mechanism to cause the potentially fatal disease granulocytic anaplasmosis. The bacterium’s adhesin, Asp14, contributes to invasion by virtue of its C terminus engaging an unknown receptor. Yeast-two hybrid analysis identified protein disulfide isomerase (PDI) as an Asp14 binding partner. Coimmunoprecipitation confirmed the interaction and validated it to be Asp14 C terminus dependent. PDI knockdown and antibody-mediated inhibition of PDI reductase activity impaired A. phagocytophilum infection of but not binding to host cells. Infection during PDI inhibition was rescued when the bacterial but not host cell surface disulfide bonds were chemically reduced with tris(2-carboxyethyl)phosphine-HCl (TCEP). TCEP also restored bacterial infectivity in the presence of an Asp14 C terminus blocking antibody that otherwise inhibits infection. A. phagocytophilum failed to productively infect myeloid-specific-PDI conditional-knockout mice, marking the first demonstration of in vivo microbial dependency on PDI for infection. Mutational analyses identified the Asp14 C-terminal residues that are critical for binding PDI. Thus, Asp14 binds and brings PDI proximal to A. phagocytophilum surface disulfide bonds that it reduces, which enables cellular and in vivo infection.
机译:不同的细胞内病原体依赖于真核细胞表面二硫化物还原酶以侵入宿主细胞。这些酶的药理学抑制是细胞毒性的,使治疗不切实际。鉴定和机械化解剖的微生物蛋白,即共选择表面还原酶可以揭示用于破坏这种常见感染策略的新靶标。 Anaplasma吞噬蛋白通过未完全定义的机制侵入中性粒细胞,以引起潜在的致命疾病粒细胞包膜症。细菌的粘附素ASP14借助于其C末端接合未知受体的侵袭。酵母 - 两种杂化分析确定蛋白二硫化物异构酶(PDI)作为ASP14结合伴侣。 CoimMunoprecipipIpipipitipitip确认了相互作用并验证了它是ASP14 C末端依赖性。 PDI敲低和抗体介导的PDI还原酶活性损害A.吞噬细胞感染但不与宿主细胞结合。当细菌但不宿主细胞表面二硫键和Tris(2-羧乙基)膦-HCl(TCEP)进行化学减少时,救出了PDI抑制期间的感染。 TCEP还在否则抑制感染的ASP14 C末端阻断抗体存在下恢复细菌感染性。 A.吞噬细胞素未能高效地感染骨髓细胞样PDI条件敲除小鼠,标志着体内微生物依赖性对PDI进行感染的第一次证明。突变分析鉴定了对结合PDI至关重要的ASP14 C末端残基。因此,ASP14结合并将PDI近端与A.吞噬表面二硫键,其降低,这使得能够进行细胞和体内感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号